These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23055712)

  • 21. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers.
    Ko HK; Hsu WH; Hsieh CC; Lien TC; Lee TS; Kou YR
    Respirology; 2014 Feb; 19(2):253-261. PubMed ID: 24372740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
    Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.
    Magalhães J; Santos SD; Saraiva MJ
    Int J Exp Pathol; 2010 Dec; 91(6):515-21. PubMed ID: 20804537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD.
    Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M
    Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
    Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
    Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
    Halper-Stromberg E; Yun JH; Parker MM; Singer RT; Gaggar A; Silverman EK; Leach S; Bowler RP; Castaldi PJ
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):500-509. PubMed ID: 29206476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of toll-like receptors on CD14+ monocytes from patients with chronic obstructive pulmonary disease and smokers].
    Pan MM; Sun TY; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2103-7. PubMed ID: 19080469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
    Wanschitz J; Ehling R; Löscher WN; Künz B; Deisenhammer F; Kuhle J; Budka H; Reindl M; Berger T
    J Neurol; 2008 Jun; 255(6):917-24. PubMed ID: 18712293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?
    Andelid K; Tengvall S; Andersson A; Levänen B; Christenson K; Jirholt P; Åhrén C; Qvarfordt I; Ekberg-Jansson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():689-702. PubMed ID: 25848245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.
    Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC
    J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung CD57+ cell density is increased in very severe COPD.
    Olloquequi J; García-Valero J; Rodríguez E; Montero MA; Ferrer J; Montes JF
    Histol Histopathol; 2012 Jan; 27(1):39-47. PubMed ID: 22127595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteoglycan 4 is a diagnostic biomarker for COPD.
    Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of immunodominant epitopes of alpha-crystallins recognized by antibodies in sera of patients with uveitis.
    Doycheva D; Preuss B; Deuter C; Zierhut M; Klein R
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):297-305. PubMed ID: 21842131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers.
    Ma A; Wen L; Yin J; Hu Y; Yue X; Li J; Dong X; Gupta Y; Ludwig RJ; Krauss-Etschmann S; Riemekasten G; Petersen F; Yu X
    Int J Chron Obstruct Pulmon Dis; 2020; 15():189-200. PubMed ID: 32099344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
    Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
    APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.